Swastika Bioremedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 31 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.82 Cr
- Revenue Growth -82.19%
- Profit Growth -1884.94%
- Ebitda -69.28%
- Net Worth 121.10%
- Total Assets -71.73%
About Swastika Bioremedies
Swastika Bioremedies Pvt Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 1993 and has a history of 31 years and ten months. Its registered office is in Chandigarh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹1.82 Cr.
Dinesh Aggarwal and Rakhi Aggarwal serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231CH1993PTC013194
-
Company No.
013194
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 1993
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Swastika Bioremedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Aggarwal
|
Managing Director | 09-Oct-1996 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Rakhi Aggarwal
|
Director | 01-Jul-2021 | Current |
Financial Performance of Swastika Bioremedies.
Swastika Bioremedies Pvt Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 82.19% decrease. The company also saw a substantial fall in profitability, with a 1884.94% decrease in profit. The company's net worth Soared by an impressive increase of 121.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Swastika Bioremedies?
In 2022, Swastika Bioremedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kay Emm Biomedicals Private LimitedRakhi Aggarwal is a mutual person
Charges (Loans)
₹18.23 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 1.53 Cr
- Others : 0.18 Cr
- Punjab Natinal Bank : 0.08 Cr
- Dena Bank : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Jun 2019 | Others | ₹1.83 M | Open |
| 24 Aug 2011 | Punjab National Bank | ₹0.50 M | Open |
| 25 Aug 2008 | Punjab National Bank | ₹4.00 M | Open |
| 14 Sep 2007 | Punjab National Bank | ₹8.00 M | Open |
| 14 Sep 2007 | Punjab National Bank | ₹2.50 M | Open |
How Many Employees Work at Swastika Bioremedies?
Unlock and access historical data on people associated with Swastika Bioremedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swastika Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swastika Bioremedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
